ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression

Clinical trial NCT07327034 · RECRUITING

Trial details

NCT number: NCT07327034
Sponsor: Abbisko Therapeutics Co, Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2025-06-13
Primary completion: 2027-06-30
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.